Suchergebnisse - "Connor, M J"

PubPharm (269)

1

Leveraging Pyrazolium Ylide Reactivity to Access Indolizine and 1,2-Dihydropyrimidine Derivatives

enthalten in: Chemistry (Weinheim an der Bergstrasse, Germany) | 2024

von Tran, R. | Brownsey, D. | O'Sullivan, L. | +6

2

Diagnostic accuracy of magnetic resonance imaging targeted biopsy techniques compared to transrectal ultrasound guided biopsy of the prostate : a systematic review and meta-analysis

enthalten in: Prostate cancer and prostatic diseases | 2022

von Bass, E. | Pantovic, A. | Connor, M. | +5

3

The influence of mechanical Circulatory support on post-transplant outcomes in pediatric patients : A multicenter study from the International Society for Heart and Lung Transplantation (ISHLT) Registry

enthalten in: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation | 2021

von Edelson, J. | Huang, Y. | Griffis, H. | +9

4

A meta-analysis of reversion mutations in BRCA genes identifies signatures of DNA end-joining repair mechanisms driving therapy resistance

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2021

von Tobalina, L. | Armenia, J. | Irving, E. | +2

5

A Multicenter Study of the Clinical Utility of Nontargeted Systematic Transperineal Prostate Biopsies in Patients Undergoing Pre-Biopsy Multiparametric Magnetic Resonance Imaging

enthalten in: The Journal of urology | 2020

von Connor, M. | Eldred-Evans, D. | van Son, M. | +16

CommentIn: J Urol. 2020 Dec;204(6):1201. - PMID 32970521

6

Cytoreductive cryotherapy for newly diagnosed oligometastatic hormone-sensitive prostate cancer

enthalten in: Prostate cancer and prostatic diseases | 2020

von Connor, M. | Winkler, M. | Ahmed, H.

CommentOn: Prostate Cancer Prostatic Dis. 2020 Mar;23(1):184-193. - PMID 31611635

7

Focal therapy for localized prostate cancer in the era of routine multi-parametric MRI

enthalten in: Prostate cancer and prostatic diseases | 2020

von Connor, M. | Gorin, M. | Ahmed, H. | +1

8

RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2018

von Cruz, C. | Castroviejo-Bermejo, M. | Gutiérrez-Enríquez, S. | +39

9

The PARP inhibitor AZD2461 provides insights into the role of PARP3 inhibition for both synthetic lethality and tolerability with chemotherapy in preclinical models

enthalten in: Cancer research | 2016

von Oplustil O'Connor, L. | Rulten, S. | Cranston, A. | +16

10

Webinar Deciphering cancer: Genomic instability in cancer

enthalten in: Science | 2016

von O'Connor, M. | Whetstine, J.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[27]